Former Elan chief set for top Malin role

Irish life sciences investment firm Malin will appoint director and former Elan chief Kelly Martin as its chief executive as part of a reshuffle of its management team, two sources close to the company said yesterday.

Malin was set up earlier this year by executives from former Irish stock market stalwart Elan, a pharmaceuticals firm, and raised €330m in one of Europe’s biggest biotechnology IPOs.

Malin’s current chief executive Adrian Howd, a former equity analyst at Berenberg Bank, will assume the newly established role of chief investment officer to concentrate on progressing the smaller, as yet unlisted companies Malin has acquired, the sources said.